SOX9 and in situ carcinoma: Although most non-invasive and non-muscle layer invasive urothelial carcinoma tissues showed negative or weakly positive intensity, SOX9 levels were significantly upregulated in muscle invasive urothelial carcinoma and carcinoma in situ (Figure 1).